Maito, Alfhaiser M.

HRN: 16-23-02  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/27/2023
CEFUROXIME 1.5GM (VIAL)
05/27/2023
06/03/2023
IVTT
470mg
Q8h
PCAP C
Checking Final Appropriateness 
05/28/2023
METRONIDAZOLE 500MG (TAB)
05/28/2023
06/05/2023
ORAL
500mg
Tid
Thickly MSAF
Checking Final Appropriateness 
05/29/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/29/2023
06/04/2023
IV
1400mg
Q8
Pcap
Checking Final Appropriateness 
05/31/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/31/2023
06/07/2023
IV
70mg
Q8h
Pcap C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: